Cargando…
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
BACKGROUND: Dystonia is a key symptom in corticobasal syndrome (CBS), and upper limb dystonia is the most common phenotype. Dystonia‐associated pain is frequently reported and can be disabling, with poor benefit from oral treatments. AIMS OF THE STUDY: To investigate the role of botulinum toxin A (B...
Autores principales: | Unti, Elisa, Mazzucchi, Sonia, Calabrese, Rosanna, Palermo, Giovanni, Del Prete, Eleonora, Bonuccelli, Ubaldo, Ceravolo, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576166/ https://www.ncbi.nlm.nih.gov/pubmed/31074111 http://dx.doi.org/10.1002/brb3.1182 |
Ejemplares similares
-
Freezing of gait and dementia in parkinsonism: A retrospective case–control study
por: Palermo, Giovanni, et al.
Publicado: (2019) -
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020) -
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011) -
Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
por: Elefante, Camilla, et al.
Publicado: (2021) -
Quantitative susceptibility mapping in atypical Parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2019)